Subscribe to RSS
DOI: 10.1055/a-1541-7964
Recommendations of the AGG (Section Maternal Disease) for Myasthenia Gravis in Pregnancy
Article in several languages: English | deutsch
Abstract
Myasthenia gravis is an autoimmune disease with a range of clinical presentations which manifest as combinations of weakness of the ocular, bulbar, and respiratory muscle groups and muscles of the extremities. Young women of reproductive age are most commonly affected. Preconception planning, the impact of pregnancy, prepartum management, drug therapy in pregnancy, myasthenic and cholinergic crises, fetal monitoring, peripartum management including analgesia and anesthesia during labor and cesarean section as well as neonatal management and neonatal myasthenia gravis are described here and the appropriate recommendations are given.
Publication History
Received: 18 June 2021
Accepted after revision: 29 June 2021
Article published online:
08 December 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References/Literatur
- 1 Varner M. Myasthenia gravis and pregnancy. Clin Obstet Gynecol 2013; 56: 372-381
- 2 Hamel J, Ciafaloni E. An Update: Myasthenia Gravis and Pregnancy. Neurol Clin 2018; 36: 355-365
- 3 Sanders DB, Wolfe GI, Benatar M. et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 2016; 87: 419-425
- 4 Massey JM, De Jesus-Acosta C. Pregnancy and myasthenia gravis. Continuum (Minneap Minn) 2014; 20: 115-127
- 5 Norwood F, Dhanjal M, Hill M. et al. Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry 2014; 85: 538-543
- 6 Stafford IP, Dildy GA. Myasthenia gravis and pregnancy. Clin Obstet Gynecol 2005; 48: 48-56
- 7 Ducci RD, Lorenzoni PJ, Kay CS. et al. Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul Disord 2017; 27: 352-357
- 8 Rolbin WH, Levinson G, Shnider SM. et al. Anesthetic considerations for myasthenia gravis and pregnancy. Anesth Analg 1978; 57: 441-447
- 9 Cheng I, Lin CH, Lin MI. et al. Outcome of myasthenia gravis mothers and their infants. Acta Paediatr Taiwan 2007; 48: 141-145
- 10 Gveric-Ahmetasevic S, Colić A, Elvedji-Gasparović V. et al. Can neonatal myasthenia gravis be predicted?. J Perinat Med 2008; 36: 503-506
- 11 Wiendl H. et al. Diagnostik und Therapie der Myasthenia gravis und des Lambert-Eaton-Syndroms, S2k-Leitlinie, 2014. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Accessed June 14, 2021 at: https://dgn.org/leitlinien/ll-68-ll-diagnostik-und-therapie-der-myasthenia-gravis-und-des-lambert-eaton-syndroms/